Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chantiya Chanswangphuwana"'
Autor:
Thiti Asawapanumas, Nichthida Tangnantachai, Narittee Sukswai, Thammathorn Assanasen, Chantiya Chanswangphuwana, Panisinee Lawsut, Chantana Polprasert, Ponlapat Rojnuckarin, Udomsak Bunworasate, Kitsada Wudhikarn
Publikováno v:
Acta Haematologica. 145:542-552
Programmed cell death (PD)/PD-ligands (PD-Ls) pathway plays an important role in the regulation of physiologic immune response. Several cancers, including lymphoma exhibit abnormal PD-1/PD-Ls expression, which may contribute to treatment failure, pro
Autor:
Chantiya Chanswangphuwana, Chantana Polprasert, Weerapat Owattanapanich, Smith Kungwankiattichai, Adisak Tantiworawit, Thanawat Rattanathammethee, Wasithep Limvorapitak, Supawee Saengboon, Pimjai Niparuck, Teeraya Puavilai, Jakrawadee Julamanee, Pirun Saelue, Chinadol Wanitpongpun, Chajchawan Nakhakes, Kannadit Prayongratana, Chantrapa Sriswasdi
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(12)
Secondary acute myeloid leukemia (sAML) and AML with myelodysplasia-related changes (AML-MRC) both result in dismal outcomes. This retrospective study aimed to determine whether these features are poor prognostic factors independent of older age and
Autor:
Narittee Sukswai, Thiti Asawapanumas, Chantiya Chanswangphuwana, San Krittikarux, Thamathorn Assanasen, Kitsada Wudhikarn, Nichthida Tangnuntachai
Publikováno v:
Leukemia & Lymphoma. 61:3395-3403
The frequency and significance of programmed cell death ligand (PD-L) 2 expression in diffuse large B cell lymphoma (DLBCL) remain undefined. We described the expression pattern of PD-L/PD-1 in 88 DLBCL patients using immunohistochemistry. The associ
Autor:
Pimjai Niparuck, Ponlapat Rojnuckarin, Thanawat Rattanathammethee, Sunisa Kongkiatkamon, Theerin Lanamtieng, Sasinipa Trithiphen, Kritanan Songserm, Chantiya Chanswangphuwana, Udomsak Bunworasate, Amornchai Suksusut, Sirorat Kobbuaklee, Panisinee Lawasut, Suporn Chuncharunee, Chantana Polprasert
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(5)
BACKGROUND : Unexplained cytopenia (UC) and low-risk myelodysplastic syndrome (MDS) are distinguished mainly by morphologic dysplasia, which sometimes shows inter-observer discrepancy. We hypothesized that gene mutations are strong prognostic factors
Autor:
Pirun Saelue, Pimjai Niparuck, Eakkapol Utchariyaprasit, Chantiya Chanswangphuwana, Chantarapa Sriswasdi, Nonglak Kanitsap, Chajchawan Nakhakes, Kannadit Prayongratana, Wasithep Limvorapitak, Ekarat Rattarittamrong, Chinadol Wanitpongpun, Chantana Polprasert, Jakrawadee Julamanee, Teeraya Puavilai, Weerapat Owattanapanich, Adisak Tantiworawit
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:e509-e514
Background Elderly patients with acute myeloid leukemia (AML) have a poorer prognosis than younger ones. Several factors contribute to the poor outcomes for this patient group. Patients and Methods This study investigated the epidemiology, clinical c
Autor:
Ran Reshef, Stephan A. Grupp, Janna Baez, Carrie L. Kitko, Paibel Aguayo-Hiraldo, Gregory A. Yanik, Aaron Etra, Yi-Bin Chen, Ryotaro Nakamura, Rachel Young, Muna Qayed, Steven Kowalyk, Umut Ozbek, Tal Schechter, William J. Hogan, John E. Levine, Stelios Kasikis, Matthias Wölfl, Daniela Weber, Elizabeth O. Hexner, Hannah Choe, Isha Gandhi, George Morales, Francis Ayuk, Wolf Rösler, Zachariah DeFilipp, Pietro Merli, Nora Rebeka Javorniczky, James L.M. Ferrara, Elisabeth Meedt, Makda Getachew Zewde, Chantiya Chanswangphuwana
Publikováno v:
Transplant Cell Ther
Acute graft-versus-host disease (GVHD) is a major cause of mortality in patients undergoing hematopoietic cell transplantation (HCT) for hematologic malignancies. The skin is the most commonly involved organ in GVHD. Elafin, a protease inhibitor over